BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Diagnosis
7495 results:

  • 1. Periorbital cellulitis as the initial presentation of acute lymphoblastic leukaemia.
    Han-Menz C; Kozgar SAM; Rana MS
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38749518
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs.
    Heim D; Baldomero H; Medinger M; Masouridi-Levrat S; Schanz U; Nair G; Güngör T; Halter J; Passweg JR; Chalandon Y;
    Swiss Med Wkly; 2024 May; 154():3754. PubMed ID: 38749067
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical Characteristics and diagnosis of Ph-Positive Mixed Phenotype Acute leukemia.
    Zhang X; Li R; Zhang X; Li J; Li X; Chen J; Li H
    Clin Lab; 2024 May; 70(5):. PubMed ID: 38747916
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Triple Trouble.
    Diwan A; Barsode S
    J Assoc Physicians India; 2024 Mar; 72(3):97-99. PubMed ID: 38736127
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].
    Zhang XS; Liu BC; Du X; Zhang YL; Xu N; Liu XL; Li WM; Lin H; Liang R; Chen CY; Huang J; Yang YF; Zhu HL; Pan L; Wang XD; Li GH; Liu ZG; Zhang YQ; Liu ZF; Hu JD; Liu CS; Li F; Yang W; Meng L; Han YQ; Lin LE; Zhao ZY; Tu CQ; Zheng CF; Bai YL; Zhou ZP; Chen SN; Qiu HY; Yang LJ; Sun XL; Sun H; Zhou L; Liu ZL; Wang DY; Guo JX; Pang LP; Zeng QS; Suo XH; Zhang WH; Zheng YJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):215-224. PubMed ID: 38716592
    [No Abstract]    [Full Text] [Related]  

  • 6. Intracranial residual lesions following early intensification in a patient with T-cell acute lymphoblastic leukemia: a case report.
    Nagamatsu Y; Isoda T; Inaji M; Oyama J; Niizato D; Tomomasa D; Mitsuiki N; Yamashita M; Kamiya T; Imai K; Kanegane H; Morio T; Takagi M
    BMC Pediatr; 2024 May; 24(1):304. PubMed ID: 38704558
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. "Myeloid" Mutations in ALL Are Not Uncommon: Implications for Etiology and Therapies.
    Iacobucci I
    Blood Cancer Discov; 2024 May; 5(3):142-145. PubMed ID: 38689559
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Obesity and risk of relapse in patients with Acute Lymphoblastic leukemia: A retrospective study].
    Ramos-Peñafiel CO; Bejarano-Rosales MP; Gallardo-Rodríguez AG; Pérez-Sámano D; Leyton-Rivera HR; Olarte-Carrillo I; Martínez-Tovar A; Tarlovsky VF; Barranco-Lampón G; Alvarez-Altamirano K
    Rev Med Chil; 2023 May; 151(5):600-609. PubMed ID: 38687542
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CRKL but not CRKII contributes to hemin-induced erythroid differentiation of cml.
    Guo C; Lv X; Zhang Q; Yi L; Ren Y; Li Z; Yan J; Zheng S; Sun MZ; Liu S
    J Cell Mol Med; 2024 May; 28(9):e18308. PubMed ID: 38683131
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cytogenetic abnormalities and TP53 and RAS gene profiles of childhood acute lymphoblastic leukemia in Morocco.
    Skhoun H; El Fessikh M; El Alaoui Al Abdallaoui M; Khattab M; Belkhayat A; Chebihi ZT; Hassani A; Abilkassem R; Agadr A; Dakka N; El Baghdadi J
    Arch Pediatr; 2024 May; 31(4):238-244. PubMed ID: 38679547
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France.
    Alcazer V; Le Meur G; Roccon M; Barriere S; Le Calvez B; Badaoui B; Spaeth A; Kosmider O; Freynet N; Eveillard M; Croizier C; Chevalier S; Sujobert P
    Lancet Digit Health; 2024 May; 6(5):e323-e333. PubMed ID: 38670741
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Testicular involvement in pediatric lymphoid tumors: a review of the literature and a series of clinical observation].
    Korneeva M S; Batmanova N A; Panferova T R; Valiev T T
    Urologiia; 2024 Mar; (1):107-112. PubMed ID: 38650415
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impact of the COVID-19 pandemic on utilization and cost for care of pediatric and young adult ALL.
    Hoover A; Watson D; Reimche P; Tanner L; Gilchrist L; Finch M; Messinger YH; Turcotte LM
    BMC Res Notes; 2024 Apr; 17(1):112. PubMed ID: 38644484
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical applications of abnormal DNA methylation in chronic myeloid leukemia.
    Zhou L; Yin X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 49(1):122-127. PubMed ID: 38615173
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia.
    Yu CH; Su YH; Jou ST; Lu MY; Lin CY; Lin KH; Chang HH; Chou SW; Huang YH; Lin DT; Lin SW; Chen HY; Chang YH; Yang YL
    Pathol Res Pract; 2024 Apr; 256():155287. PubMed ID: 38579576
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid leukemia Cells.
    Tezcanli Kaymaz B; Gumus N; Celik B; Alcitepe İ; Biray Avci C; Aktan C
    J Interferon Cytokine Res; 2024 Apr; 44(4):178-189. PubMed ID: 38579140
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Neuropsychological task outcomes among survivors of childhood acute lymphoblastic leukemia in Malaysia.
    Alias H; Mohd Ranai N; Lau SCD; de Sonneville LMJ
    Sci Rep; 2024 Apr; 14(1):7915. PubMed ID: 38575744
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Discontinuation of tyrosine kinase inhibitors before epiphyseal closure leading to improved short stature in pediatric chronic myelogenous leukemia].
    Fukui W; Ogura T; Azumi S; Ogata H; Kawaguchi K; Takachi T; Horikoshi Y; Uematsu A; Shimada H; Watanabe K
    Rinsho Ketsueki; 2024; 65(3):175-179. PubMed ID: 38569862
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
    Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
    Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The Screening of microRNAs in Chronic Myeloid leukemia: A Clinical Evaluation.
    Wosniaki DK; Marin AM; Oliveira RN; Koerich GM; Munhoz EC; Farias JSH; Beltrame MP; Zanette DL; Aoki MN
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542337
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 375.